Easy, fast and reproducible analysis of host cell protein (HCP) in monoclonal antibody preparations
Applications | 2019 | Thermo Fisher ScientificInstrumentation
Host cell proteins (HCPs) are residual impurities derived from the cells used to produce monoclonal antibodies (mAbs). Even at low concentrations, these contaminants can impact drug safety, efficacy, and long-term stability. Sensitive, reproducible methods for monitoring HCP profiles are therefore critical in biopharmaceutical quality control and regulatory compliance.
This study demonstrates an integrated, automated workflow for HCP analysis in a commercial mAb product. It combines automated magnetic bead digestion with high-resolution peptide mapping and charge variant analysis. The goals were:
An automated digestion protocol using the SMART Digest kit on the KingFisher Duo Prime achieved complete mAb sequence coverage and identified 51 HCPs. Six proteins were confirmed by two or more unique peptides. Among these, cathepsin L1, a protease that cleaves the His-Thr motif, was detected at ~4 ppm (ng HCP per mg mAb).
Charge variant analysis coupled to Orbitrap MS revealed low molecular weight mAb fragments consistent with cathepsin L1 activity. Peptide mapping at a high digest load (160 µg) maintained >100% sequence coverage and reproducible chromatographic performance, with only a minor reduction in resolution and asymmetry compared to standard 5 µg loads.
Further integration of data-independent acquisition and parallel reaction monitoring could enhance quantitation of trace HCPs. Machine learning models trained on high-resolution MS data may predict HCP risk profiles and guide process optimization. Expanded HCP libraries from diverse host cell lines will improve coverage of unexpected contaminants.
The described automated UHPLC-Orbitrap platform delivers robust peptide mapping and deep HCP analysis in a single workflow. Identification of cathepsin L1 at low ppm levels demonstrates the method’s sensitivity and underscores the importance of comprehensive HCP monitoring for mAb product quality.
LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap
IndustriesPharma & Biopharma
ManufacturerThermo Fisher Scientific
Summary
Importance of the Topic
Host cell proteins (HCPs) are residual impurities derived from the cells used to produce monoclonal antibodies (mAbs). Even at low concentrations, these contaminants can impact drug safety, efficacy, and long-term stability. Sensitive, reproducible methods for monitoring HCP profiles are therefore critical in biopharmaceutical quality control and regulatory compliance.
Objectives and Study Overview
This study demonstrates an integrated, automated workflow for HCP analysis in a commercial mAb product. It combines automated magnetic bead digestion with high-resolution peptide mapping and charge variant analysis. The goals were:
- To develop a rapid, reproducible protocol for both HCP characterization and routine peptide mapping
- To identify low-abundance protease contaminants that may contribute to mAb degradation
- To evaluate chromatographic and mass spectrometric performance at high sample loads
Instrumentation
- KingFisher Duo Prime purification system with SMART Digest magnetic beads for automated tryptic digestion
- Vanquish Flex Binary UHPLC with Acclaim VANQUISH C18, 2.1 × 250 mm column for peptide separation and HCP analysis
- Q Exactive Plus Hybrid Quadrupole-Orbitrap mass spectrometer for high-resolution accurate mass detection
- Chromeleon CDS and Biopharma Finder for data processing, and PEAKS Studio for HCP database searches
Key Results and Discussion
An automated digestion protocol using the SMART Digest kit on the KingFisher Duo Prime achieved complete mAb sequence coverage and identified 51 HCPs. Six proteins were confirmed by two or more unique peptides. Among these, cathepsin L1, a protease that cleaves the His-Thr motif, was detected at ~4 ppm (ng HCP per mg mAb).
Charge variant analysis coupled to Orbitrap MS revealed low molecular weight mAb fragments consistent with cathepsin L1 activity. Peptide mapping at a high digest load (160 µg) maintained >100% sequence coverage and reproducible chromatographic performance, with only a minor reduction in resolution and asymmetry compared to standard 5 µg loads.
Benefits and Practical Applications
- Automated magnetic bead digestion reduces hands-on time and improves reproducibility across replicate preparations
- The same UHPLC-MS workflow supports both routine peptide mapping and deep HCP profiling without hardware changes
- Detection of low-abundance proteases like cathepsin L1 enables identification of degradation pathways and supports formulation stability studies
Future Trends and Opportunities
Further integration of data-independent acquisition and parallel reaction monitoring could enhance quantitation of trace HCPs. Machine learning models trained on high-resolution MS data may predict HCP risk profiles and guide process optimization. Expanded HCP libraries from diverse host cell lines will improve coverage of unexpected contaminants.
Conclusion
The described automated UHPLC-Orbitrap platform delivers robust peptide mapping and deep HCP analysis in a single workflow. Identification of cathepsin L1 at low ppm levels demonstrates the method’s sensitivity and underscores the importance of comprehensive HCP monitoring for mAb product quality.
References
- Kim JY, Kim YG, Lee GM. Appl Microbiol Biotechnol. 2012;93:917–930.
- Tscheliessnig AL, Konrath J, Bates R, Jungbauer A. Biotechnol J. 2013;8:655–670.
- Shukla AA et al. Biotechnol Prog. 2008;24:615–622.
- Doneanu C et al. MAbs. 2012;4:24–44.
- Zhu-Shimoni J et al. Biotechnol Bioeng. 2014;111:2367–2379.
- Kreimer S et al. Anal Chem. 2017;89:5294–5302.
- McGivney JB et al. Anal Chem. 2018;90:3262–3269.
- Kumar A et al. J Proteome Res. 2015;14:4687–4703.
- Füssl F et al. MAbs. 2019;11(1):116–128.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Residual host cell protein analysis of NISTmAb: From simplified sample preparation to reliable results
2020|Thermo Fisher Scientific|Applications
APPLICATION NOTE 73412 Residual host cell protein analysis of NISTmAb: From simplified sample preparation to reliable results Authors: Amy Claydon, Phil Widdowson, and Andrew Williamson Thermo Fisher Scientific, Hemel Hempstead, UK Keywords: Host cell protein assay, HCP, monoclonal antibody, mAb,…
Key words
denaturing, denaturingdigest, digestnistmab, nistmabhcp, hcpprotein, proteinhcps, hcpsdigestion, digestionsmart, smartnon, nonpeptides, peptidesmab, mabintrasample, intrasamplehost, hostdynamic, dynamickingfisher
Comprehensive identification and label-free quantitation of host cell protein contaminants using BioPharma Finder 4.1 software
2021|Thermo Fisher Scientific|Applications
APPLICATION NOTE 74109 Comprehensive identification and label-free quantitation of host cell protein contaminants using BioPharma Finder 4.1 software Authors: Silvia Millán-Martín,1 Sara Carillo,1 Jonathan Bones1, Jennifer Sutton2 National Institute for Bioprocessing Research and Training (NIBRT), Dublin, Ireland 1 2 Thermo…
Key words
protein, proteinhcp, hcphcps, hcpshost, hostsetting, settingpeptide, peptidemass, masspeptides, peptidesvanquish, vanquishthermo, thermolipase, lipaselipoprotein, lipoproteinscientific, scientificproteins, proteinsprotease
Protein solutions eBook
2024|Thermo Fisher Scientific|Guides
Biopharma Protein solutions eBook Protein therapeutics: At a glance Protein therapeutics are a type of biotherapeutics derived from genetically engineered human proteins. They offer several advantages over small-molecule drugs, allowing for more precise targeting of complex functions. Compared to chemical…
Key words
thermo, thermoscientific, scientificprotein, proteinorbitrap, orbitrapvanquish, vanquishanalysis, analysisintact, intactuhplc, uhplcduo, duobiopharma, biopharmacharacterization, characterizationpeptide, peptideattribute, attributemapping, mappingsubunit
Accelerating biotherapeutic development
2024|Thermo Fisher Scientific|Brochures and specifications
Biopharma By your side Accelerating biotherapeutic development Enabling every step of your biotherapeutic development We equip you to overcome today’s and tomorrow’s challenges with tools and expertise to advance life-changing biotherapeutics to market faster than ever before. Your molecules are…
Key words
thermo, thermoscientific, scientificorbitrap, orbitrapvanquish, vanquishprotein, proteinuhplc, uhplcanalysis, analysischaracterization, characterizationlearn, learnintact, intactworkflow, workflowbiopharma, biopharmaduo, duomapping, mappingbiotherapeutic